Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -20.51%1.29M | -26.29%1.3M | -7.96%1.74M | -9.32%6.59M | -15.81%1.34M | -20.41%1.62M | -0.66%1.76M | 0.70%1.89M | -8.77%7.27M | -21.71%1.59M |
| Operating revenue | -17.99%1.28M | -20.41%1.29M | -5.42%1.74M | -9.52%6.49M | -11.47%1.34M | -22.31%1.56M | -8.23%1.62M | -1.96%1.84M | -9.32%7.17M | -23.02%1.52M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -1.66%1.7M | -17.71%1.67M | -3.56%2.01M | 3.70%8.91M | -0.36%2.83M | -10.38%1.73M | 3.21%2.02M | 12.07%2.08M | -3.10%8.59M | 34.46%2.84M |
| Selling and administrative expenses | -1.37%1.19M | -3.72%1.4M | -1.38%1.66M | 6.64%7.11M | 15.64%2.67M | -23.96%1.21M | -3.68%1.45M | 21.45%1.68M | -2.82%6.67M | 59.69%2.31M |
| -Selling and marketing expense | 12.88%1.12M | 9.00%914.95K | 16.31%1.17M | 3.30%5.04M | 27.23%1.78M | -19.61%992.25K | -28.93%839.37K | -5.30%1.01M | -2.56%4.88M | -57.73%1.4M |
| -General and administrative expense | -66.80%71.8K | -21.20%481.61K | -27.92%484.3K | 15.73%2.07M | -2.03%897.16K | -39.09%216.25K | 88.11%611.21K | 110.73%671.93K | -3.51%1.79M | 149.33%915.75K |
| Depreciation amortization depletion | 1.08%159.96K | -40.41%161.76K | -37.66%158.17K | -11.10%647.3K | -29.03%146.59K | 9.17%158.26K | 46.45%271.47K | 32.69%253.72K | -18.81%728.08K | 5.46%206.55K |
| -Depreciation and amortization | 1.08%159.96K | -40.41%161.76K | -37.66%158.17K | -11.10%647.3K | -29.03%146.59K | 9.17%158.26K | 46.45%271.47K | 32.69%253.72K | -18.81%728.08K | 5.46%206.55K |
| -Depletion | ---- | ---- | ---- | ---- | ---- | ---- | 37.10%10.65K | ---- | ---- | ---- |
| Other operating expenses | -3.82%346.91K | -64.41%107.67K | 29.57%195.4K | -3.72%1.15M | -96.20%12.33K | 86.58%360.69K | 11.93%302.53K | -47.16%150.81K | 7.87%1.2M | -31.10%324.22K |
| Operating profit | -274.45%-413.47K | -38.66%-370.91K | -39.43%-270.08K | -75.28%-2.32M | -19.32%-1.49M | -206.17%-110.42K | -38.68%-267.5K | -1,190.68%-193.7K | -47.26%-1.32M | -1,462.00%-1.25M |
| Net non-operating interest income (expenses) | 22.38%-15.91K | 34.37%-17.2K | 26.02%-18.11K | -23.59%-134.57K | 18.47%-63.38K | -97.36%-20.5K | -148.00%-26.21K | -140.26%-24.48K | -5.63%-108.88K | -187.91%-77.74K |
| Non-operating interest expense | -22.38%15.91K | -34.37%17.2K | -26.02%18.11K | 23.59%134.57K | -18.47%63.38K | 97.36%20.5K | 148.00%26.21K | 140.26%24.48K | 5.63%108.88K | 187.91%77.74K |
| Other net income (expenses) | -1,252.56%-4.76K | 1,865.16%10.13K | -3,077.00%-16.3K | -1,839.32%-17.43K | -547.15%-16.01K | 77.01%-352 | -209.75%-574 | 67.32%-513 | -82.17%1K | -75.55%3.58K |
| Gain on sale of security | -1,252.56%-4.76K | 1,865.16%10.13K | -3,077.00%-16.3K | -1,839.32%-17.43K | -547.15%-16.01K | 77.01%-352 | -209.75%-574 | 67.32%-513 | -82.17%1K | -75.55%3.58K |
| Income before tax | -230.73%-434.14K | -28.44%-377.97K | -39.23%-304.49K | -72.69%-2.47M | -18.63%-1.57M | -242.55%-131.27K | -45.02%-294.28K | -3,744.98%-218.7K | -43.68%-1.43M | -1,333.40%-1.32M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -230.73%-434.14K | -28.44%-377.97K | -39.23%-304.49K | -72.69%-2.47M | -18.63%-1.57M | -242.55%-131.27K | -45.02%-294.28K | -3,744.98%-218.7K | -43.68%-1.43M | -1,333.40%-1.32M |
| Net income continuous operations | -230.73%-434.14K | -28.44%-377.97K | -39.23%-304.49K | -72.69%-2.47M | -18.63%-1.57M | -242.55%-131.27K | -45.02%-294.28K | -3,744.98%-218.7K | -43.68%-1.43M | -1,333.40%-1.32M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -230.73%-434.14K | -28.44%-377.97K | -39.23%-304.49K | -72.69%-2.47M | -18.63%-1.57M | -242.55%-131.27K | -45.02%-294.28K | -3,744.98%-218.7K | -43.68%-1.43M | -1,333.40%-1.32M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -230.73%-434.14K | -28.44%-377.97K | -39.23%-304.49K | -72.69%-2.47M | -18.63%-1.57M | -242.55%-131.27K | -45.02%-294.28K | -3,744.98%-218.7K | -43.68%-1.43M | -1,333.40%-1.32M |
| Diluted earnings per share | -100.00%-0.02 | -100.00%-0.02 | 0.00%-0.01 | -66.67%-0.1 | -7.71%-0.06 | -365.04%-0.01 | 0.00%-0.01 | -4,165.04%-0.01 | -50.00%-0.06 | -1,370.90%-0.0557 |
| Basic earnings per share | -100.00%-0.02 | -100.00%-0.02 | 0.00%-0.01 | -66.67%-0.1 | -7.71%-0.06 | -365.04%-0.01 | 0.00%-0.01 | -4,165.04%-0.01 | -50.00%-0.06 | -1,370.90%-0.0557 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.